Literature DB >> 18668426

Determination and modelling of stereoselective interactions of ligands with drug transporters: a key dimension in the understanding of drug disposition.

P Bhatia1, M Kolinski, R Moaddel, K Jozwiak, I W Wainer.   

Abstract

1. Stereochemistry is an important dimension in pharmacology and plays a role in every aspect of the pharmacological fate of chiral xenobiotics. This includes small molecule-drug transporter binding. 2. This paper reviews the reported stereoselectivities of substrate and inhibitor interactions with P-glycoprotein and the organic cation transporter obtained using standard functional and binding studies, as well as data obtained from online cellular membrane affinity chromatography studies. 3. The use of stereochemical data in quantitative structure-activity relationship (QSAR) and pharmacophore modelling is also addressed as is the effect of ignoring the fact that small molecule-drug transporter interactions take place in three-dimensional and asymmetric space.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18668426      PMCID: PMC4632247          DOI: 10.1080/00498250802109207

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  37 in total

1.  Stereoselective transport of hydrophilic quaternary drugs by human MDR1 and rat Mdr1b P-glycoproteins.

Authors:  Guido J E J Hooiveld; Janette Heegsma; Jessica E van Montfoort; Peter L M Jansen; Dirk K F Meijer; Michael Müller
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

2.  The synthesis and initial characterization of an immobilized purinergic receptor (P2Y1) liquid chromatography stationary phase for online screening.

Authors:  Ruin Moaddel; Enrica Calleri; Gabriella Massolini; Chester R Frazier; Irving W Wainer
Journal:  Anal Biochem       Date:  2007-02-22       Impact factor: 3.365

3.  Affinities at the verapamil binding site of MDR1-encoded P-glycoprotein: drugs and analogs, stereoisomers and metabolites.

Authors:  S Neuhoff; P Langguth; C Dressler; T B Andersson; C G Regårdh; H Spahn-Langguth
Journal:  Int J Clin Pharmacol Ther       Date:  2000-04       Impact factor: 1.366

4.  Interactions of racemic mefloquine and its enantiomers with P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT.

Authors:  Y T Pham; A Régina; R Farinotti; P Couraud; I W Wainer; F Roux; F Gimenez
Journal:  Biochim Biophys Acta       Date:  2000-12-15

5.  Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.

Authors:  J M Ford; W C Prozialeck; W N Hait
Journal:  Mol Pharmacol       Date:  1989-01       Impact factor: 4.436

6.  Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes.

Authors:  Sabine Spiegl-Kreinecker; Johanna Buchroithner; Leonilla Elbling; Elisabeth Steiner; Gabriele Wurm; Angelika Bodenteich; Johannes Fischer; Michael Micksche; Walter Berger
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

7.  Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein.

Authors:  V Höllt; M Kouba; M Dietel; G Vogt
Journal:  Biochem Pharmacol       Date:  1992-06-23       Impact factor: 5.858

8.  Pharmacophore modelling of stereoselective binding to the human organic cation transporter (hOCT1).

Authors:  R Moaddel; S Ravichandran; F Bighi; R Yamaguchi; I W Wainer
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

9.  Identification of P-glycoprotein substrates using open tubular chromatography on an immobilized P-glycoprotein column: Comparison of chromatographic results with Caco-2 permeability.

Authors:  Ruin Moaddel; Rachid Hamid; Sharvil Patel; Peter L Bullock; Irving W Wainer
Journal:  Anal Chim Acta       Date:  2006-03-10       Impact factor: 6.558

Review 10.  Future directions for drug transporter modelling.

Authors:  S Ekins; G F Ecker; P Chiba; P W Swaan
Journal:  Xenobiotica       Date:  2007 Oct-Nov       Impact factor: 1.908

View more
  6 in total

Review 1.  Bioavailability through PepT1: the role of computer modelling in intelligent drug design.

Authors:  David W Foley; Jeyaganesh Rajamanickam; Patrick D Bailey; David Meredith
Journal:  Curr Comput Aided Drug Des       Date:  2010-03       Impact factor: 1.606

2.  Characterization of solution-phase drug-protein interactions by ultrafast affinity extraction.

Authors:  Sandya R Beeram; Xiwei Zheng; Kyungah Suh; David S Hage
Journal:  Methods       Date:  2018-03-03       Impact factor: 3.608

3.  ABCC Transporters Mediate the Vacuolar Accumulation of Crocins in Saffron Stigmas.

Authors:  Olivia Costantina Demurtas; Rita de Brito Francisco; Gianfranco Diretto; Paola Ferrante; Sarah Frusciante; Marco Pietrella; Giuseppe Aprea; Lorenzo Borghi; Mistianne Feeney; Lorenzo Frigerio; Adriana Coricello; Giosuè Costa; Stefano Alcaro; Enrico Martinoia; Giovanni Giuliano
Journal:  Plant Cell       Date:  2019-09-23       Impact factor: 11.277

4.  Stereoselective regulations of P-glycoprotein by ginsenoside Rh2 epimers and the potential mechanisms from the view of pharmacokinetics.

Authors:  Jingwei Zhang; Fang Zhou; Fang Niu; Meng Lu; Xiaolan Wu; Jianguo Sun; Guangji Wang
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

Review 5.  Enantioselective Drug Recognition by Drug Transporters.

Authors:  Yuichi Uwai
Journal:  Molecules       Date:  2018-11-22       Impact factor: 4.411

6.  Stereoselective property of 20(S)-protopanaxadiol ocotillol type epimers affects its absorption and also the inhibition of P-glycoprotein.

Authors:  Wenyan Wang; Xiangmeng Wu; Li Wang; Qingguo Meng; Wanhui Liu
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.